The adult EpiPen shortage in the southeast and Canada should come to an end any day now.
Late last week Health Canada confirmed they had reached a deal with The Food and Drug Administration (FDA) in the United States to import a couple weeks' worth of EpiPens called Auvi-Q.
Myla Wollbaum, the director of professional practice at the Pharmacy Association of Saskatchewan, said she's pleased that the federal government found an alternative option.
"It's looking good that we will have another auto-injector on the market by next week and hopefully until the end of the year," she said. "Pfizer is working on providing an uninterrupted supply of the EpiPen itself."
Pfizer was Canada's lone supplier for EpiPens and for the last several months they've struggled with the production of the adult pens.
"We are not really sure what exactly the problem is, but they've had what they've cited as repeated manufacturing issues," Wollbaum said. "We don't know what that means, but it's looking like they're starting to resolve it but we have no way of telling if this would continue to be ongoing because they haven't said."
Last week Pfizer began allowing some pharmacies in Canada to begin ordering adult EpiPens again but only a select amount.